Skip to main content
SpringerLink
Log in

Therapy for Medullary Thyroid Cancer

  • Chapter
Thyroid Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Behr TM, Wulst E, Radetzky S, Blumenthal RD, Dunn RM, Gratz S, Rave-Frank M, Schmidberger H, Raue F, Becker W (1997) Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type. Cancer Res 57:5309–5319

    PubMed  Google Scholar 

  2. Bergholm U, Bergstrom R, Ekbom A (1997) Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer 79:132–138

    Article  PubMed  Google Scholar 

  3. Chi DD, Moley JF (1998) Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia. Surg Oncol Clin North Am 7:681–706

    Google Scholar 

  4. Christensen SB, Ljungberg O, Tibblin S (1984) A clinical epidemiologic study of thyroid carcinoma in Malmo, Sweden. Curr Probl Cancer 8:1–49

    Google Scholar 

  5. Decker RA, Geiger JD, Cox CE, Mackovjak M, Sarkar M, Peacock ML (1996) Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: is parathyroid transplantation indicated? World J Surg 20:814–820; discussion 820–811

    Article  PubMed  Google Scholar 

  6. Dilla T, Velasco JA, Medina DL, Gonzalez-Palacios JF, Santisteban P (2000) The MDM 2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells. Endocrinology 141:420–429

    PubMed  Google Scholar 

  7. Dottorini ME, Assi A, Sironi M, Sangalli G, Spreafico G, Colombo L (1996) Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathological variables. Cancer 77:1556–1565

    Article  PubMed  Google Scholar 

  8. Dralle H, Damm I, Scheumann GF, Kotzerke J, Kupsch E, Geerlings H, Pichlmayr R (1994) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112–121

    PubMed  Google Scholar 

  9. Dralle H, Gimm O (1996) Lymph node excision in thyroid carcinoma. Chirurg 67:788–806

    PubMed  Google Scholar 

  10. Dralle H, Gimm O, Simon D, Frank-Raue K, Gortz G, Niederle B, Wahl RA, Koch B, Walgenbach S, Hampel R, Ritter MM, Spelsberg F, Heiss A, Hinze R, Hoppner W (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22:744–750; discussion 750–741

    Article  PubMed  Google Scholar 

  11. Dralle H, Scheumann GF, Kotzerke J, Brabant EG (1992) Surgical management of MEN 2. Rec Res Cancer Res 125:167–195

    Google Scholar 

  12. Dralle H, Scheumann GF, Proye C, Bacourt F, Frilling A, Limbert F, Gheri G, Henry JF, Berner M, Niederle B et al (1995) The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study. J Intern Med 238:357–361

    PubMed  Google Scholar 

  13. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjold M, Komminoth P, Hendy GN, Gharib H, Thibodeau SN, Lacroix A, Frilling A, Ponder BA, Mulligan LM (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575–1579

    PubMed  Google Scholar 

  14. Fleming JB, Lee JE, Bouvet M, Schultz PN, Sherman SI, Sellin RV, Friend KE, Burgess MA, Cote GJ, Gagel RF, Evans DB (1999) Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 230:697–707

    Article  PubMed  Google Scholar 

  15. Frank-Raue K, Ziegler R, Raue F (1993) The use of octreotide in the treatment of medullary thyroid carcinoma. Horm Metab Res [Suppl] 27:44–47

    Google Scholar 

  16. Freyer G, Dazord A, Schlumberger M, Conte-Devolx B, Ligneau B, Trillet-Lenoir V, Lenoir GM (1999) Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: a multicentric pilot-evaluation. Ann Oncol 10:87–95

    Article  Google Scholar 

  17. Gimm O, Dralle H (1997) Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified? Surgery 122:1124–1130; discussion 1130–1121

    Article  PubMed  Google Scholar 

  18. Gimm O, Dralle H (1999) C-cell cancer — prevention and treatment. Langenbecks Arch Surg 384:16–23

    PubMed  Google Scholar 

  19. Gimm O, Ukkat J, Dralle H (1998) Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 22:562–567; discussion 567–568

    Article  PubMed  Google Scholar 

  20. Hazard JB, Hawk WA, Crile G (1959) Medullary (solid) carcinoma of the thyroid — a clinicopathological entity. J Clin Endocrinol Metab 19:152–161

    PubMed  Google Scholar 

  21. Hoie J, Jorgensen OG, Stenwig AE, Langmark F (1988) Medullary thyroid cancer in Norway. A 30-year experience. Acta Chir Scand 154:339–343

    PubMed  Google Scholar 

  22. Horn RC (1951) Carcinoma of the thyroid: description of a distinctive morphological variant and report of seven cases. Cancer 4:697–707

    Google Scholar 

  23. Jaquet AJ (1906) Ein Fall von metastasierenden Amyloidtumoren (Lymphosarcoma). Virchows Archiv (Pathol Anat) 185:251

    Google Scholar 

  24. Juweid M, Sharkey RM, Behr T, Swayne LC, Herskovic T, Pereira M, Rubin AD, Hanley D, Dunn R, Siegel J, Goldenberg DM (1996) Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. J Nucl Med 37:905–911

    PubMed  Google Scholar 

  25. Kebebew E, Tresler PA, Siperstein AE, Duh QY, Clark OH (1999) Normal thyroid pathology in patients undergoing thyroidectomy for finding a RET gene germline mutation: a report of three cases and review of the literature. Thyroid 9:127–131

    PubMed  Google Scholar 

  26. Machens A, Behrmann C, Dralle H (2000) Chemoembolization of liver metastases from medullary thyroid carcinoma. Ann Intern Med 132:596–597

    PubMed  Google Scholar 

  27. Machens A, Gimm O, Hinze R, Hoppner W, Boehm BO, Dralle H (2001) Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties. J Clin Endocrinol Metab 86:1104–1109

    Article  PubMed  Google Scholar 

  28. Mahler C, Verhelst J, de Longueville M, Harris A (1990) Long-term treatment of metastatic medullary thyroid carcinoma with the somatostatin analogue octreotide. Clin Endocrinol (Oxf) 33:261–269

    Google Scholar 

  29. Marzano LA, Porcelli A, Biondi B, Lupoli G, Delrio P, Lombardi G, Zarrilli L (1995) Surgical management and follow-up of medullary thyroid carcinoma. J Surg Oncol 59:162–168

    PubMed  Google Scholar 

  30. Miyauchi A, Matsuzuka F, Hirai K, Yokozawa T, Kobayashi K, Ito Y, Nakano K, Kuma K, Futami H, Yamaguchi K (2002) Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations. World J Surg 26:1023–1028

    PubMed  Google Scholar 

  31. Moley JF (1995) Medullary thyroid cancer. Surg Clin North Am 75:405–420

    PubMed  Google Scholar 

  32. Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–887; discussion 887–888

    Article  PubMed  Google Scholar 

  33. Moley JF, Dilley WG, DeBenedetti MK (1997) Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg 225:734–740; discussion 740–733

    Article  PubMed  Google Scholar 

  34. Moley JF, Wells SA, Dilley WG, Tisell LE (1993) Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 114:1090–1095; discussion 1095–1096

    PubMed  Google Scholar 

  35. Niccoli-Sire P, Murat A, Baudin E, Henry JF, Proye C, Bigorgne JC, Bstandig B, Modigliani E, Morange S, Schlumberger M, Conte-Devolx B (1999) Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. Eur J Endocrinol 141:468–474

    PubMed  Google Scholar 

  36. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A (1994) Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma (see Comments). J Clin Endocrinol Metab 78:826–829

    PubMed  Google Scholar 

  37. Ponder BA, Ponder MA, Coffey R, Pembrey ME, Gagel RF, Telenius-Berg M, Semple P, Easton DF (1988) Risk estimation and screening in families of patients with medullary thyroid carcinoma. Lancet 1:397–401

    PubMed  Google Scholar 

  38. Raue F, Kotzerke J, Reinwein D, Schroder S, Roher HD, Deckart H, Hofer R, Ritter M, Seif F, Buhr H et al (1993) Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. Clin Invest 71:7–12

    Article  Google Scholar 

  39. Rieu M, Lame MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL, Fombeur JP (1995) Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules (see Comments). Clin Endocrinol (Oxf) 42:453–460

    Google Scholar 

  40. Stein R, Chen S, Reed L, Richel H, Goldenberg DM (2002) Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine. Cancer 94:51–61

    Article  PubMed  Google Scholar 

  41. Van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM (1990) Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212:395–400; discussion 400–401

    PubMed  Google Scholar 

  42. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B (1997) Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589–1593

    PubMed  Google Scholar 

  43. Wells SA Jr, Baylin SB, Gann DS, Farrell RE, Dilley WG, Preissig SH, Linehan WM, Cooper CW (1978) Medullary thyroid carcinoma: relationship of method of diagnosis to pathological staging. Ann Surg 188:377–383

    PubMed  Google Scholar 

  44. Wells SA Jr, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, Ivanovich JL, De-Benedetti MK, Dilley WG, Moley JF et al (1994) Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 220:237–247; discussion 247–250

    PubMed  Google Scholar 

  45. Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB (2003) Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Arch Surg 138:409–416; discussion 416

    PubMed  Google Scholar 

Download references

Authors
  1. O. Gimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Dralle
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Nuklearmedizin, Rheinische Friedrich-Wilhelms-Universität, Sigmund-Freud-Strasse 25, 53127, Bonn, Germany

    H.-J. Biersack (Professor Dr. med.) (Professor Dr. med.)

  2. Klinik für Nuklearmedizin, Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany

    F. Grünwald (Professor Dr. med.) (Professor Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gimm, O., Dralle, H. (2005). Therapy for Medullary Thyroid Cancer. In: Biersack, HJ., Grünwald, F. (eds) Thyroid Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27845-1_19

Download citation

  • DOI: https://doi.org/10.1007/3-540-27845-1_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22309-2

  • Online ISBN: 978-3-540-27845-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation